Levosimendan improves postresuscitation outcomes in a rat model of CPR

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 5, 2005, Pages 256-261

  Huang, Lei ^b   Weil, Max Harry ^a   Sun, Shijie ^b   Cammarata, Gianluca ^b   Cao, Lan ^b   Tang, Wanchun ^b  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM SENSITIZER; DOBUTAMINE; LEVOSIMENDAN; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CIRCULATION; COMPRESSION THERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEFIBRILLATION; DIASTOLE; DRUG EFFECT; DRUG EFFICACY; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART RATE; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; RAT; RESUSCITATION; SURVIVAL TIME;

ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIAC OUTPUT; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DOBUTAMINE; HEART ARREST; HEART RATE; HYDRAZONES; MALE; PYRIDAZINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SINGLE-BLIND METHOD; SURVIVAL RATE; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 26844579375     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.07.005     Document Type: Article

References (29)

1. American Heart Association Heart and stroke facts 1991 American Heart Association Dallas, TX
2. National Heart, Lung, and Blood Institute Morbidity and mortality chart book on cardiovascular, lung, and blood diseases 1990 1990 National Institutes of Health Bethesda, MD
3. W. Tang, M.H. Weil, S.J. Sun, R.J. Gazmuri, J. Bisera Progressive myocardial dysfunction after cardiac resuscitation Crit Care Med 21 1993 1046 1050
4. W. Tang, M.H. Weil, S. Sun, M. Noc, L. Yang, R.J. Gazmuri Epinephrine increases the severity of postresuscitation myocardial dysfunction Circulation 92 1995 3089 3093
5. R.J. Gazmuri, M.H. Weil, J. Bisera, W. Tang, M. Fukui, D. McKee Myocardial dysfunction after successful resuscitation from cardiac arrest Crit Care Med 24 1996 992 1000
6. K.B. Kern, R.W. Hilwig, K.H. Rhee, R.A. Berg Myocardial dysfunction after resuscitation from cardiac arrest an example of global myocardial stunning J Am Coll Cardiol 28 1996 232 240
7. E.L. Cerchiari, P. Safer, E. Klein, R. Cantadore, M. Pinsky Cardiovascular function and neurological outcome after cardiac arrest in dogs Resuscitation 25 1993 9 33
8. H.J. Deantonio, S. Kaul, B.B. Lerman Reversible myocardial depression in survivors of cardiac arrest Pacing Clin Electrophysiol 13 1990 982 985
9. I. Laurent, M. Monchi, J.D. Chiche Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest J Am Coll Cardiol 40 2002 2110 2116
10. R.R. Liberthson, E.L. Nagel, J.C. Hirschman Prehospital ventricular defibrillation. Prognosis and follow-up course N Engl J Med 291 1974 317 321
11. K.B. Kern, R.W. Hilwig, R.A. Berg Postresuscitation left ventricular systolic and diastolic dysfunction treatment with dobutamine Circulation 95 1997 2610 2613
12. M.R. Bristow, R.E. Hershberger, J.D. Port Beta-adrenergic pathways in non-failing and failing human ventricular myocardium Circulation 82 suppl I 1990 I-12 I-25
13. W.S. Colucci, G.F. Leatheman, P.L. Ludmer, D.F. Gauthier β-Adrenergic inotropic responsiveness of patients with heart failure studies with intracoronary dobutamine infusion Circ Res 61 pt 2 1987 I-82 I-86
14. J. Lilleberg, M.S. Nieminen, J. Akkila Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting Eur Heart J 19 1998 660 668
15. H. Ukkonen, M. Saraste, Akkila Myocardial efficiency during levosimendan infusion in congestive heart failure Clin Pharmacol Ther 68 2000 522 531
16. H. Haikala, J. Kaivola, E. Nissinen, P. Wall, J. Levijoki, I.B. Linden Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan J Mol Cell Cardiol 27 1995 1859 1866
17. J. Levijoki, P. Pollesello, J. Kaivola Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan structure-response and binding analysis with analogs of levosimendan J Mol Cell Cardiol 32 2000 479 491
18. B.N. Singh, J. Lilleberg, E.P. Sandell, V. Ylonen, L. Lehtonen, L. Towenen Effects of levosimendan on cardiac arrhythmia electrophysiologic and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure Am J Cardiol 83 1999 16 20
19. F. Follath, J.G. Cleland, H. Just Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study) a randomized double-blind trial Lancet 360 2002 196 202
20. I. Von Planta, M.H. Weil Cardiopulmonary resuscitation in the rat J Appl Physiol 65 1988 2641 2647
21. S.J. Sun, M.H. Weil, W. Tang, H.P. Povoas Combined effects of buffer and adrenergic agent on postresuscitation myocardial function J Pharmacol Exp Ther 291 1999 773 777
22. W.S. Colucci, R.F. Wright, E. Braunwald New positive inotropic agents in the treatment of congestive heart failure mechanisms of action and recent clinical developments N Engl J Med 314 1986 349 358
23. L.W. Stevenson, W.S. Colucci Management of patients hospitalized with heart failure T.W. Smith Cardiovascular therapeutics 1996 Saunders Philadelphia, PA 199 209
24. C.V. Leier, P.F. Binkley Parenteral inotropic support for advanced congestive heart failure Prog Cardiovasc Dis 41 1998 207 224
25. M.T. Slawsky, W.S. Colucci, S.S. Gottlieb Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure Circulation 102 2000 2222 2227
26. G. Hasenfuss, C. Holubarsch, H.W. Heiss Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone Circulation 80 1989 51 64
27. J.C. Lee, S.E. Downing Cyclic AMP and the pathogenesis of myocardial injury Res Commun Chem Pathol Pharmacol 27 1980 305 318
28. T. Podzuweit, W.F. Lubbe, L.H. Opie Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrythemic drugs Lancet 1 1976 341 342
29. F. Folláth, S. Hinkka, Jäer Detlef Dose-ranging and safety with intravenous levosimendan in low-output heart failure experience in three pilot studies and outline of levosimendan infusion versus dobutamine (LIDO) trial Am J Cardiol 83 1999 I-21 I-25